ArticleScience advances2025

Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models.

Virginia Metrangolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.